REST EZ operates as a micro-cap OTC-traded supplement company focused exclusively on the sleep-aid category with all-natural ingredients. The company employs a multi-channel distribution strategy spanning e-commerce and traditional retail, though limited public disclosure constrains visibility into market share, revenue trends, and growth trajectory.
Cyborg Score Rationale
REST EZ is a micro-cap ($27.5M) sleep-aid supplement company with minimal analyst coverage (0 analysts) and sparse financial disclosure. The OTC listing, volatile stock price history, and lack of recent material developments suggest capital constraints and limited operational scale.
Top Insights
Micro-cap sleep supplement player in a mature, competitive market dominated by large consumer health companies
All-natural formulation targeting health-conscious consumers, but brand recognition and market penetration likely limited
Zero analyst coverage indicates minimal institutional investor interest and limited capital for growth initiatives
OTC trading suggests limited regulatory scrutiny and potential operational or disclosure challenges
Named Competitors
Sleep Aid Supplements — Leading over-the-counter sleep and wellness supplements
Sleep Supplements — Sleep aid and wellness supplement manufacturer
Sleep Products — Retail nutrition and sleep supplement retailer
Open the full interactive REST EZ Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.